Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 4Sarcoma 1

Conditions

Skin Neoplasms 1Neoplasms, Adnexal and Skin Appendage 1Melanoma 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Mohs Surgery × Sarcoma × Clear all
NCT02310503 2020-05-05

REGESMOHS

Fundación Academia Española de Dermatología

Completed
6,000 enrolled
DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms, Dermatofibrosarcoma, Neoplasms, Adnexal and Skin Appendage, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡